iapharm

pharmacy & data science

Navigation menu

  • Blog
  • About
  • Podcast
  • Articles
  • Pharmacy & History
  • Llibres
  • Books
  • GitHub
  • Links
  • Contact

Categories

Archives

  • març 2026
  • maig 2025
  • abril 2025
  • març 2025
  • febrer 2025
  • gener 2025
  • juny 2024
  • maig 2024
  • abril 2024
  • març 2024
  • gener 2024
  • desembre 2023
  • novembre 2023
  • octubre 2023
  • setembre 2023
  • agost 2023
  • juliol 2023
  • juny 2023
  • maig 2023
  • abril 2023
  • març 2023
  • febrer 2023
  • gener 2023
  • desembre 2022
  • novembre 2022
  • octubre 2022
  • setembre 2022
  • juliol 2022
  • juny 2022
  • maig 2022
  • abril 2022
  • març 2022
  • febrer 2022
  • desembre 2021
  • novembre 2021
  • octubre 2021

Search

  • Artificial Intelligence,  Education

    Inici del programa AI4ALL, intel·ligència artificial aplicada a la indústria

    14 setembre 2022 /

    El 13 de setembre es va inaugurar la quarta edició del Programa AI4ALL amb l’objectiu d’incorporar encara més la intel·ligència artificial a la indústria catalana.  El programa està organitzat conjuntament pel Parc de Recerca de la Universitat Autònoma de Barcelona (UAB), l’Institut d’Investigació en Intel·ligència Artificial del CSIC, el Centre de Visió per Computador i l’Escola d’Enginyeria de la UAB.… Read more

    llegir-ne més
  • Prescription

    La recepta, del paper a l’era digital

    14 juliol 2022 /

    En els darrers anys els ministeris de Salut de la majoria de països europeus han fet un gran esforç per digitalitzar el sistema de dispensació de medicaments. Així, tot posant l’usuari al centre s’ha treballat per augmentar i millorar la seguretat en la dispensació, l’autonomia del pacient, la relació amb els sanitaris i l’observança en el tractament.… Read more

    llegir-ne més
  • European Comission,  European Parliament

    European Parliament examines the use of artificial intelligence in healthcare

    16 juny 2022 /

    A recently published Panel for the Future of Science and Technology (STOA) study examines the use of artificial intelligence in healthcare. It explores applications, risks, and ethical and social impacts in the context of the EU member states.

    This study offers an overview of how AI can benefit future healthcare, but at the same time it identifies and clarifies the main clinical, social and ethical risks posed by AI in healthcare.… Read more

    llegir-ne més
  • Cibersecurity

    Ciberseguridad en la oficina de farmacia

    19 maig 2022 /

    La ciberseguridad es una asignatura pendiente en muchas oficinas de farmacia. La falta de recursos y conocimientos propicia vulnerabilidades que pueden ser fatales a corto y largo plazo. Por esta razón, colaboré con la redacción del artículo Ciberseguridad  en el día a día de una oficina de farmacia, publicado en el Blog del Club de la Farmacia.… Read more

    llegir-ne més
  • Artificial Intelligence,  Deep learning

    Application of deep learning-based automated pain assessment in critically ill patients

    5 abril 2022 /

    A recent study published in Frontiers in Medicine established the deep learning-based pain classifier based on facial expression focusing on the area nearby eyebrow. The accuracy to detect tense/grimacing and grimacing were ~80 and 90%, respectively. This study, entitled ‘Deep Learning-Based Pain Classifier Based on the Facial Expression in Critically Ill Patients‘, indicates a real-world application of AI-based pain assessment based on the facial expression in ICU.… Read more

    llegir-ne més
  • Artificial Intelligence

    An artificial intelligence solution to alleviate the shortage of drugs

    1 març 2022 /

    In recent years, the global shortage of drugs has increased. Furthermore, this crisis has reached an alarming level during the COVID-19 crisis. According to the American Society of Health-Systems Pharmacists (ASHP), close to 200 drugs are currently on the drug shortage list in the U.S. In Europe, drug shortages increased in 65% of pharmacies, according to the results of the survey carried out by the European Pharmaceutical Group (PGEU).… Read more

    llegir-ne més
  • Blockchain,  Distribution

    Blockchain improves drug supply chain security

    3 febrer 2022 /

    In recent years, Western countries have tried to digitise dispensing drugs. In any case, a significant percentage of the prescriptions issued by private doctors are on paper. Furthermore, in countries like Spain, many public health doctors are still reluctant to use electronic prescriptions. 

    This causes serious problems. There is a high percentage of counterfeit prescriptions that cannot be verified by pharmacists.… Read more

    llegir-ne més
  • Artificial Intelligence,  Distribution

    AI and pharma cold chain

    29 desembre 2021 /

    In the coming years, we will see an increase in the distribution of biological medicines. This new situation will cause the transformation of the cold chain of the pharmaceutical supply chain. However, Artificial Intelligence will play a key role in the development of the cold chain. Furthermore, in conjunction with machine learning and predictive analytics, AI transformation goes much deeper than smarter search functions.… Read more

    llegir-ne més
  • Distribution

    The role of AI in Pharma distribution companies

    14 novembre 2021 /

    Pharmaceutical distribution companies are moving towards implementing artificial intelligence (AI) to gain efficiency. Now, in 2021, AI can provide pharmacy sales activities, competitor prices and their margins, sociodemographic information, location, etc.

    Unlike other technologies, AI helps to better understand the characteristics of each pharmacy.

    AI would help distribution companies to evolve from marketing with personalisation to hyper personalisation.… Read more

    llegir-ne més
  • European Comission

    European pharmaceutical strategy goes through data science

    5 octubre 2021 /

    On 25 November 2020, the European Commission published its Pharmaceutical Strategy for Europe, which aims to create a futureproof regulatory framework and to support industry in promoting research and new technologies.

    This strategy will be based on 4 pillars:

    · Ensuring access to affordable drugs for patients, and addressing unmet medical needs.

    · Supporting the competitiveness, innovation and sustainability of the EU pharmaceutical industry and the development of high quality, safe, effective and greener medicines.… Read more

    llegir-ne més
Publicacions més recent 

Search

2026 Iapharm ©
  • Política de galetes (EU)
  • Legal notice
  • Privacy police
Ashe Tema de WP Royal.
Manage Cookie Consent
Utilitzem galetes per optimitzar el nostre lloc web i el nostre servei.
Funcional Sempre actiu
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferències
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Estadístiques
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Màrqueting
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Gestiona les opcions Gestiona els serveis Manage {vendor_count} vendors Read more about these purposes
Mostra les preferències
{title} {title} {title}